First Trust Advisors’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $87.6M | Sell |
|
|||||
|
2024
Q4 | $64M | Buy |
|
|||||
|
2024
Q3 | $49.8M | Buy |
|
|||||
|
2024
Q2 | $40M | Sell |
|
|||||
|
2024
Q1 | $47.8M | Buy |
|
|||||
|
2023
Q4 | $775K | Sell |
|
|||||
|
2023
Q3 | $3.26M | Buy |
|
|||||
|
2023
Q2 | $1.39M | Sell |
|
|||||
|
2023
Q1 | $2.73M | Buy |
|
|||||
|
2022
Q4 | $1.67M | Sell |
|
|||||
|
2022
Q3 | $4.49M | Sell |
|
|||||
|
2022
Q2 | $6.16M | Buy |
|
|||||
|
2022
Q1 | $5.97M | Buy |
|
|||||
|
2021
Q4 | $3.08M | Sell |
|
|||||
|
2021
Q3 | $4.11M | Buy |
|
|||||
|
2021
Q2 | $2.12M | Buy |
|
|||||
|
2019
Q1 | – | Sell |
|
|||||
|
2018
Q4 | $274K | Buy |
|